Showing results (171-180 of 4,754) with videos related to
Sort By:
Pageof 476
Transplantation|July 1, 1988
Immunosuppression of graft rejection with idarubicin-monoclonal antibody conjugates by elimination of T cell subsets in vivoM J Smyth, G A Pietersz, I F McKenzieImmunogenetics|July 1, 1980
Studies of H-2Kb mutant mice. II. Definition of new H-2 specificities (H-2.68, 69, 71, 72) using the H-2Kb mutant, B6.C-H-2bm10G M Morgan, I F McKenzie, R W MelvoldTransplantation|January 15, 1995
Biochemical studies of pig xenoantigens detected by naturally occurring human antibodies and the galactose alpha(1-3)galactose reactive lectinH A Vaughan, I F McKenzie, M S SandrinJournal of Immunogenetics|December 1, 1982
Ly- and ecotropic MuLV antigens are separate entitiesW Y Langdon, I F McKenzie, G R ShellamJournal of Drug Targeting|January 1, 1994
Enhanced antitumour effects using a combination of two antibodies conjugated to different drugsA J Rowland, I F McKenzie, G A PieterszTransplantation|July 1, 1989
The effect of idarubicin monoclonal antibody treatment of first-set rejection of murine skin allograftsM J Smyth, I F McKenzie, G A PieterszBiochemical and Biophysical Research Communications|October 31, 1991
Identification of four different CD46 (MCP) molecules with anti-peptide antibodiesD F Purcell, R W Jonstone, I F McKenzieImmunogenetics|January 1, 1985
The mouse Ly-17 locus identifies a polymorphism of the Fc receptorM L Hibbs, P M Hogarth, I F McKenzieJournal of the National Cancer Institute|October 1, 1982
Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factorsW J Halliday, T A Koppi, I F McKenzieJournal of Immunological Methods|January 1, 1980
A new procedure for analysing the relationship between different cell surface antigensC R Parish, H C O'Neill, I F McKenziePageof 476